Combining immunotherapy approaches in myeloma. Inner circle depicts the idiotype (Id) vaccine trial schema used by Qazilbash et al. Opportunities to combine other immunotherapy approaches are depicted in the outer circle. ADCs, antibody-drug conjugates; ASCT, autologous stem cell transplant; HD, high dose; TME, tumor microenvironment.